morpholine has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, E; Hosseini-Kharat, M; Mehri Lighvan, Z; Mohammadi, T; Momtazi-Borojeni, AA; Rahimi, R; Sharifi, T; Tavakol, H; Zargarian, D | 1 |
| Kuhajda, FP; Simpson, PJ; Tu, Y; Zhou, W | 1 |
| Andricopulo, AD; Carneiro, JW; Dias, LC; Krogh, R; Lanznaster, M; Pinto, AC; Ribeiro, NM; Silva, BV; Vargas, MD | 1 |
3 other study(ies) available for morpholine and Breast Neoplasms
| Article | Year |
|---|---|
Antiproliferative activity of morpholine-based compounds on MCF-7 breast cancer, colon carcinoma C26, and normal fibroblast NIH-3T3 cell lines and study of their binding affinity to calf thymus-DNA and bovine serum albumin.
Topics: Animals; Binding Sites; Breast Neoplasms; Cattle; Cell Death; Cell Proliferation; Circular Dichroism; Colonic Neoplasms; Density Functional Theory; DNA; Female; Fibroblasts; Humans; Kinetics; MCF-7 Cells; Mice; Molecular Docking Simulation; Morpholines; NIH 3T3 Cells; Nucleic Acid Denaturation; Serum Albumin, Bovine; Thermodynamics | 2019 |
Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
Topics: Amino Acids, Neutral; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carboxy-Lyases; Cell Line, Tumor; Enzyme Inhibitors; Fatty Acid Synthases; Fatty Acids; Fibroblasts; Humans; Immunoblotting; Models, Biological; Morpholines; RNA, Small Interfering | 2009 |
Synthesis, electrochemical studies and anticancer activity of ferrocenyl oxindoles.
Topics: Antineoplastic Agents; Breast Neoplasms; Catalysis; Cell Line, Tumor; Electrochemical Techniques; Female; Ferrous Compounds; Humans; Indoles; Isomerism; Metallocenes; Morpholines; Oxidation-Reduction; Oxindoles | 2010 |